Market Cap N/A
Revenue (ttm) N/A
Net Income (ttm) N/A
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin N/A
Debt to Equity Ratio N/A
Volume 10,245
Avg Vol N/A
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K N/A
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

Radiopharm Theranostics Limited a clinical-stage radiotherapeutics company, engages in the research and development of radiopharmaceutical products for diagnostic and therapeutic uses in areas with high unmet medical needs. The company develops several products, including RAD101, a pivalate brain metastasis diagnostic; RAD102, a pivalate therapeutic; RAD201a, a Nano-mAb HER-2 breast diagnostic; RAD202, a Nano-mAb HER-2 breast therapeutic; RAD203, a Nano-mAb PDL1 non-small cell lung diagnostic; a...

Industry: Biotechnology
Sector: Healthcare
Phone: 61 3 9824 5254
Fax: 61 3 9822 7735
Address:
62 Lygon Street, Level 3, Carlton, Australia
RadioIsotope25
RadioIsotope25 Mar. 21 at 8:30 PM
RAD101 upcoming phase 2b data potentially unlocks $RADX against its peers $TLX $LNTH and potentially re-rates stock. Estimated phase 2b completion March 31st, 2026…
1 · Reply
Lalalilala
Lalalilala Mar. 21 at 6:35 PM
$RADX Assuming the upcoming data is good, at what price do you think they'll make the offer following these results? I can't even figure out how many shares are in the Nasdaq's free float, that's how bad it is... The best thing for us is for it to be bought out before the new data is released... I can't manage my sale outside of market hours, and it's very frustrating, a bit like on December 15th when I still managed to do well! Frustrating to see it priced at over $20 and only be able to sell at $13.50... I'm convinced the same thing will happen with the next data release. Of course, the data is good... I think there's still a long way to go for RadX, and it's a bit early to talk about a buyout today, but perhaps it could still happen within the next 24 months. To be honest with everyone, that's my number one wish. Have a good weekend. It's still so difficult to buy stocks here, especially when you want to buy them as cheaply as possible. 🚑
1 · Reply
PrometheusFlame
PrometheusFlame Mar. 20 at 6:14 PM
$RADX These mm are too funny. Sat on a bid for 2 hours and not even one share filled.
1 · Reply
RadioIsotope25
RadioIsotope25 Mar. 20 at 5:46 PM
$RADX Screw you shorts!
1 · Reply
RadioIsotope25
RadioIsotope25 Mar. 20 at 5:32 PM
$RADX Only 7 trading days left before rad101 trial supposed to be finished ✔️
0 · Reply
alsworthg
alsworthg Mar. 20 at 4:19 PM
$RADX keep it down here so I can average down with fresh powder on Monday
0 · Reply
PrometheusFlame
PrometheusFlame Mar. 20 at 4:13 PM
$RADX hey mm bastards, got a bid for 100k shares at $4.44. Let’s see if you can fill it.
0 · Reply
RadioIsotope25
RadioIsotope25 Mar. 20 at 3:59 PM
0 · Reply
RadioIsotope25
RadioIsotope25 Mar. 20 at 2:21 PM
Looking for at least $12+ to profit. $RADX
0 · Reply
RadioIsotope25
RadioIsotope25 Mar. 20 at 2:19 PM
$RADX Buy low sell high. Classic setup
0 · Reply
Latest News on RADX
RAD Increases Ownership in Radiopharm Ventures to 87.5%

Mon, 12 Jan 2026 07:00:00 -0500 - 2 months ago

RAD Increases Ownership in Radiopharm Ventures to 87.5%


Why Is Radiopharm Theranostics Stock Rallying Over 140%?

Mon, 15 Dec 2025 11:59:59 -0500 - 3 months ago

Why Is Radiopharm Theranostics Stock Rallying Over 140%?


Radiopharm Theranostics Limited - Special Call

2025-09-02T05:15:35.000Z - 7 months ago

Radiopharm Theranostics Limited - Special Call


Dr Oliver Sartor Appointed to Radiopharm Scientific Advisory Board

Tue, 22 Jul 2025 08:00:00 -0400 - 8 months ago

Dr Oliver Sartor Appointed to Radiopharm Scientific Advisory Board


ITM and Radiopharm Sign Supply Agreement for n.c.a. Lutetium-177

Mon, 19 May 2025 08:00:00 -0400 - 10 months ago

ITM and Radiopharm Sign Supply Agreement for n.c.a. Lutetium-177


RAD 202 Receives Approval to Start Phase 1 Therapeutic Trial

Fri, 20 Dec 2024 08:00:00 -0500 - 1 year ago

RAD 202 Receives Approval to Start Phase 1 Therapeutic Trial


RadioIsotope25
RadioIsotope25 Mar. 21 at 8:30 PM
RAD101 upcoming phase 2b data potentially unlocks $RADX against its peers $TLX $LNTH and potentially re-rates stock. Estimated phase 2b completion March 31st, 2026…
1 · Reply
Lalalilala
Lalalilala Mar. 21 at 6:35 PM
$RADX Assuming the upcoming data is good, at what price do you think they'll make the offer following these results? I can't even figure out how many shares are in the Nasdaq's free float, that's how bad it is... The best thing for us is for it to be bought out before the new data is released... I can't manage my sale outside of market hours, and it's very frustrating, a bit like on December 15th when I still managed to do well! Frustrating to see it priced at over $20 and only be able to sell at $13.50... I'm convinced the same thing will happen with the next data release. Of course, the data is good... I think there's still a long way to go for RadX, and it's a bit early to talk about a buyout today, but perhaps it could still happen within the next 24 months. To be honest with everyone, that's my number one wish. Have a good weekend. It's still so difficult to buy stocks here, especially when you want to buy them as cheaply as possible. 🚑
1 · Reply
PrometheusFlame
PrometheusFlame Mar. 20 at 6:14 PM
$RADX These mm are too funny. Sat on a bid for 2 hours and not even one share filled.
1 · Reply
RadioIsotope25
RadioIsotope25 Mar. 20 at 5:46 PM
$RADX Screw you shorts!
1 · Reply
RadioIsotope25
RadioIsotope25 Mar. 20 at 5:32 PM
$RADX Only 7 trading days left before rad101 trial supposed to be finished ✔️
0 · Reply
alsworthg
alsworthg Mar. 20 at 4:19 PM
$RADX keep it down here so I can average down with fresh powder on Monday
0 · Reply
PrometheusFlame
PrometheusFlame Mar. 20 at 4:13 PM
$RADX hey mm bastards, got a bid for 100k shares at $4.44. Let’s see if you can fill it.
0 · Reply
RadioIsotope25
RadioIsotope25 Mar. 20 at 3:59 PM
0 · Reply
RadioIsotope25
RadioIsotope25 Mar. 20 at 2:21 PM
Looking for at least $12+ to profit. $RADX
0 · Reply
RadioIsotope25
RadioIsotope25 Mar. 20 at 2:19 PM
$RADX Buy low sell high. Classic setup
0 · Reply
watchaddict
watchaddict Mar. 20 at 1:46 PM
$RADX adding
1 · Reply
RadioIsotope25
RadioIsotope25 Mar. 20 at 1:36 PM
$RADX Something is cooking. Stock didn’t trade for first 3 hours on asx. Then some guy sold $297 worth to market it down. Definite hard buy zone here!
0 · Reply
RadioIsotope25
RadioIsotope25 Mar. 20 at 1:16 PM
Get ready shorts to get radiated $RADX
0 · Reply
Lalalilala
Lalalilala Mar. 20 at 12:19 PM
$RADX Hello everyone! Could someone please post a link showing the daily updated short selling prices on $RADX?
3 · Reply
PaulWalter
PaulWalter Mar. 20 at 11:39 AM
$RADX When are the next catalysts? Thanks.
0 · Reply
RadioIsotope25
RadioIsotope25 Mar. 19 at 8:46 PM
0 · Reply
RadioIsotope25
RadioIsotope25 Mar. 19 at 7:00 PM
0 · Reply
Lalalilala
Lalalilala Mar. 19 at 5:08 PM
$RADX I'm taking the risk of waiting until it's below $4 to buy for €70,000. I truly believe the news will come out between June 15th and 30th. Everything must be well-written and tightly plotted. The deal needs to be the most beautiful in the world for this data, which will lead to either a buyout or dilution to pursue further costly studies. We'll see. I'd like it to stabilize above $15 after June to continue the adventure. It's frustrating to sell just because we know it will collapse after the data release... but a buyout could happen when no one expects it. Good luck to everyone, whatever happens!
1 · Reply
RadioIsotope25
RadioIsotope25 Mar. 19 at 4:35 PM
$RADX No pain no gain. It was very painful last time waiting for good news. Is what it is.
0 · Reply
RadioIsotope25
RadioIsotope25 Mar. 19 at 3:08 PM
Securing Radiopharma and GLP-1 Supply Chains Through 2026 M&A | Pharmaceutical Technology $RADX https://www.pharmtech.com/view/securing-radiopharma-and-glp-1-supply-chains-through-2026-m-a
0 · Reply
RadioIsotope25
RadioIsotope25 Mar. 19 at 2:56 PM
$RADX Same thing happened last time then it went ballistic
0 · Reply
alsworthg
alsworthg Mar. 19 at 2:36 PM
$RADX this needs news and PR badly!!!!
1 · Reply